GlassScriptPhysician profile
Larry D Hayes
NPI 1528149234
$624.87
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $101 · 2022: $38.13 · 2023: $199 · 2024: $18.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $167.14 | 2019 | |
| Organogenesis INC. | $113.47 | 2020-2023 | Puraply |
| Acera Surgical, INC. | $89.11 | 2019 | |
| Horizon Therapeutics Plc | $73.38 | 2019-2023 | Krystexxa |
| Abbott Laboratories | $38.33 | 2023 | Octrode |
| Paratek Pharmaceuticals, INC. | $33.93 | 2020 | |
| Medtronic, INC. | $31.86 | 2023-2024 | Intellis Adaptivestim |
| Kerecis Limited | $19.70 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Zyla Life Sciences, INC. | $16.76 | 2020 | |
| Angiodynamics, INC. | $16.45 | 2020 | |
| Alfasigma USA, INC. | $13.56 | 2022 | |
| Smith+Nephew, INC. | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Hayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.